Europe Vaccines Market Highlights
| Report Name | Europe Vaccines Market |
| Forecast period | 2025-2031 |
| Forecast Size | USD 44.5 billion by 2031 |
| CAGR | 6.8% |
| Growing Sector | Healthcare |
Topics Covered in the Europe Vaccines Market Report
Europe Vaccines Market report thoroughly covers the market by countries, by technology, by type, by disease indication, by route of administration, and by patient type. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Europe Vaccines Market Size & Analysis
The Europe Vaccines Market is projected to reach a value of USD 44.5 billion by 2031, growing at a CAGR of 6.8% during the forecast period (2025-2031). This can be attributed to various factors such as increasing government initiatives for vaccination programs, rising awareness about the benefits of immunization, and advancements in vaccine technology.
Europe Vaccines Market Synopsis
The vaccines market in Europe is a significant contributor to the growing healthcare industry. With advanced research and development capabilities, European countries have been at the forefront of vaccine innovation and technology. The Europe vaccines market is expected to witness steady growth in the coming years due to increasing government initiatives for vaccination programs, rising awareness about preventive healthcare, and a growing demand for novel vaccines.
According to 6Wresearch, the Europe Vaccines Market size is estimated to reach at a CAGR of 6.8% during the forecast period 2025-2031. One of the major drivers of the Europe vaccines market is the increasing incidence of infectious diseases. With a rise in global travel and immigration, there has been an increase in the spread of diseases across borders, leading to a greater demand for vaccinations. Additionally, factors such as rising healthcare expenditure, advancements in technology, and a growing elderly population have also contributed to the growth of the vaccines market in Europe. The Europe vaccines industry is witnessing several trends and innovations that are shaping its future. One such trend is the development of personalized vaccines for individuals based on their genetic makeup. This approach not only increases the effectiveness of vaccines but also reduces the risk of adverse reactions. Furthermore, there has been a growth in research and development for novel vaccines, including those targeting emerging infectious diseases and cancer.
Government Initiatives Introduced in the Europe Vaccines Market
Governments in Europe are playing a crucial role in promoting vaccination programs and driving market growth. Many countries have implemented mandatory vaccination policies, while others offer free or subsidized vaccinations to their citizens. The European Union has also taken initiatives to improve vaccine research and production, such as the Innovative Medicines Initiative (IMI) and the European Vaccine Action Plan.
Key Players in the Europe Vaccines Market
The Europe vaccines market is dominated by several key players that contribute to research, development, and distribution. Companies like GlaxoSmithKline, Pfizer, Merck, Sanofi, and AstraZeneca lead the market with their extensive portfolio of vaccines and continuous efforts in innovation and development.
Future Insights of the Europe Vaccines Market
The Europe vaccines market growth is poised for significant growth driven by technological advancements, an ageing population, and the rising prevalence of infectious diseases. Personalized vaccines will likely become more mainstream, offering tailored immunity based on individual genetic profiles. Additionally, mRNA vaccine technology, showcased prominently during the COVID-19 pandemic, is expected to revolutionize vaccine development, offering quicker production times and adaptable platforms for multiple diseases.
Market Analysis by Country
According to Dhaval, Research Manager, 6Wresearch, Germany takes a leading position. This country's prominence in the market can be attributed to its robust healthcare infrastructure, significant investments in research and development, and the presence of leading pharmaceutical companies.
Market Analysis by Disease Indication
Based on the disease indications, pneumococcal disease and influenza stand out as leading infections driving the demand for vaccines in the Europe market. Pneumococcal vaccines are crucial due to the high incidence of pneumococcal diseases, including pneumonia, meningitis, and sepsis, especially among children and the elderly.
Key attractiveness of the report
- 10 Years Market Numbers.
- Historical Data Starting from 2021 to 2024.
- Base Year: 2024.
- Forecast Data until 2031.
- Key Performance Indicators Impacting the Market.
- Major Upcoming Developments and Projects.
Key Highlights of the Report:
- Europe Vaccines Market Outlook
- Market Size of Europe Vaccines Market, 2023
- Forecast of Europe Vaccines Market, 2031
- Historical Data and Forecast of Europe Vaccines Revenues & Volume for the Period 2021 - 2031
- Europe Vaccines Market Trend Evolution
- Europe Vaccines Market Drivers and Challenges
- Europe Vaccines Price Trends
- Europe Vaccines Porter's Five Forces
- Europe Vaccines Industry Life Cycle
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Technology for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Conjugate vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Inactivated and subunit vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Live attenuated vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Recombinant vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Toxoid vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Type for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Monovalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Multivalent vaccines for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
- Historical Data and Forecast of Europe Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
- Historical Data and Forecast of Germany Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
- Historical Data and Forecast of France Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
- Historical Data and Forecast of Italy Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
- Historical Data and Forecast of Russia Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
- Historical Data and Forecast of Spain Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Pneumococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By DTP for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Influenza for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By HPV for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Meningococcal disease for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Polio for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Rotavirus for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Pneumococcal disease Vaccines Market Revenues & Volume By Other disease indications for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Route of Administration for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Intramuscular and subcutaneous administration for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Oral administration for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Other routes of administration for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
- Historical Data and Forecast of Europe Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
- Historical Data and Forecast of Germany Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
- Historical Data and Forecast of United Kingdom Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
- Historical Data and Forecast of France Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
- Historical Data and Forecast of Italy Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
- Historical Data and Forecast of Russia Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
- Historical Data and Forecast of Spain Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Patient Type for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Pediatric patients for the Period 2021 - 2031
- Historical Data and Forecast of Rest of Europe Vaccines Market Revenues & Volume By Adult patients for the Period 2021 - 2031
- Europe Vaccines Market - Key Performance Indicators
- Europe Vaccines Market - Import Export Trade Statistics
- Europe Vaccines Market - Opportunity Assessment By Countries
- Europe Vaccines Market - Opportunity Assessment By Technology
- Europe Vaccines Market - Opportunity Assessment By Type
- Europe Vaccines Market - Opportunity Assessment By Disease Indication
- Europe Vaccines Market - Opportunity Assessment By Route of Administration
- Europe Vaccines Market - Opportunity Assessment By Patient Type
- Europe Vaccines Market - Top Companies Market Share
- Europe Vaccines Market - Top Companies Profiles
- Europe Vaccines Market - Comparison of Players in Technical and Operating Parameters
- Europe Vaccines Market - Strategic Recommendations
Market Covered
The report offers a comprehensive study of the subsequent market segments:
By Countries
- Germany
- United Kingdom
- France
- Italy
- Russia
- Spain
- Rest Of Europe
By Technology
- Conjugate Vaccines
- Inactivated And Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
By Type
- Monovalent Vaccines
- Multivalent Vaccines
By Disease Indication
- Pneumococcal Disease
- DTP
- Influenza
- HPV
- Meningococcal Disease
- Polio
- Rotavirus
- Other Disease Indications
By Route Of Administration
- Intramuscular And Subcutaneous Administration
- Oral Administration
- Other Routes Of Administration
By Patient Type
- Pediatric Patients
- Adult Patients
